#15221 – Men and Women with All Levels of Liver Disease

Location: Minneapolis

Stay: 5 Night/6 Days in the clinic

Gender: Male/Female

Ages: 18-75

Compensation: $1750

Smokers Allowed: Yes

Study Overview:

This study will look at what effect the body of individuals with various stages of liver disease have on on the study drug encorafenib, along with its safety and tolerability, and compare this to individuals with normal liver function. This medication is being developed for the treatment of carious types of cancers. You do not need to have cancer to participate in this study.

Enroll In This Study